On Thursday Biocon Biologics said it has appointed Kedar Upadhye as its new CFO.
Upadhye replaces MB Chinappa who will take up a finance role at the Biocon Group.
The Bengaluru-based compnay said in a statement that the leadership changes will be effective October 31, 2023, the Bengaluru-based company said in a statement.
“He (Upadhye) joins us at an inflection point in our journey to become a leading global biosimilars company as we look to consolidate and unlock value in the acquired business,” Biocon Biologics CEO & Managing Director Shreehas Tambe said.
Upadhye joins Biocon Biologics from ReNew Energy Global Plc.
Biocon Biologics is a subsidiary of Biocon Ltd.
On Thursday the company shares closed 1.3 per cent down at Rs. 235.55 on the NSE.
